DermBiont Announces Acquisition of SeylanMED to Expand Its Portfolio...

DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc....(PRWeb October 21, 2020)Read the full story at https://www.prweb.com/releases/dermbiont_announces_acquisition_of_seylanmed_to_expand_its_portfolio_of_targeted_topical_therapeutics_treating_skin_diseases_at_their_root_cause/prweb17489010.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news